IDXX

712.39

0.30% -2.16

Dopo l'orario di chiusura: 712.39

Idexx Laboratories Inc (IDXX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché IDXX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$714.55

Aprire:

$707.29

Volume 24 ore:

542.77K

Relative Volume:

1.02

Capitalizzazione di mercato:

$56.89B

Reddito:

$4.17B

Utile/perdita netta:

$1.03B

Rapporto P/E:

56.47

EPS:

12.6148

Flusso di cassa netto:

$940.22M

1 W Prestazione:

+5.30%

1M Prestazione:

+0.81%

6M Prestazione:

+32.21%

1 anno Prestazione:

+64.77%

Intervallo 1D:

$694.52

$713.99

Intervallo di 1 settimana:

$661.89

$724.99

Portata 52W:

$356.14

$769.98

Idexx Laboratories Inc Stock (IDXX) Company Profile

Nome

Idexx Laboratories Inc

Settore

Healthcare (1113)

Industria

Diagnostics & Research (53)

Telefono

(207) 556-0300

Indirizzo

ONE IDEXX DRIVE, WESTBROOK, ME

Dipendente

11,000

Cinguettio

@idexx

Prossima data di guadagno

2025-02-03

Ultimi documenti SEC

IDXX's Discussions on Twitter

Confronta IDXX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IDXX Idexx Laboratories Inc	712.39	57.06B	4.17B	1.03B	940.22M	12.61
TMO Thermo Fisher Scientific Inc	606.50	231.87B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	235.00	166.39B	24.27B	3.50B	5.02B	4.8589
IQV Iqvia Holdings Inc	243.19	41.60B	15.90B	1.28B	2.21B	7.2842
A Agilent Technologies Inc	145.76	41.90B	6.95B	1.30B	1.15B	4.5696

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Overweight
2025-10-31	Aggiornamento	Stifel	Hold → Buy
2025-10-01	Iniziato	UBS	Neutral
2025-08-05	Reiterato	BTIG Research	Buy
2025-07-01	Iniziato	Jefferies	Buy
2024-12-02	Iniziato	Leerink Partners	Outperform
2024-07-25	Iniziato	BTIG Research	Buy
2024-01-30	Downgrade	Piper Sandler	Overweight → Neutral
2023-12-07	Iniziato	Exane BNP Paribas	Outperform
2023-12-04	Aggiornamento	Cleveland Research	Neutral → Buy
2023-08-02	Downgrade	Atlantic Equities	Overweight → Neutral
2022-07-25	Downgrade	Stifel	Buy → Hold
2022-07-21	Aggiornamento	Goldman	Neutral → Buy
2022-07-12	Iniziato	Piper Sandler	Overweight
2022-05-05	Downgrade	BofA Securities	Buy → Neutral
2022-02-08	Iniziato	Atlantic Equities	Overweight
2021-11-18	Iniziato	Morgan Stanley	Overweight
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-07-12	Downgrade	Guggenheim	Buy → Neutral
2021-02-17	Iniziato	Barclays	Overweight
2019-09-09	Iniziato	Goldman	Neutral
2019-05-23	Iniziato	Guggenheim	Buy
2018-11-02	Reiterato	BofA/Merrill	Buy
2018-05-07	Reiterato	Stifel	Buy
2018-01-16	Iniziato	Piper Jaffray	Overweight
2017-08-23	Aggiornamento	BofA/Merrill	Neutral → Buy
2017-07-28	Aggiornamento	CL King	Neutral → Buy
2017-02-03	Downgrade	Feltl & Co.	Hold → Sell
2016-09-29	Ripresa	BofA/Merrill	Neutral
2016-08-16	Reiterato	Stifel	Buy
2016-08-03	Aggiornamento	Northcoast	Sell → Neutral
2016-07-20	Reiterato	Canaccord Genuity	Buy
2016-04-19	Reiterato	Canaccord Genuity	Buy
2016-04-01	Iniziato	CL King	Neutral
2016-03-21	Reiterato	Stifel	Buy
2016-02-04	Iniziato	Credit Suisse	Outperform
2015-10-29	Reiterato	Stifel	Buy
2015-08-28	Downgrade	Raymond James	Outperform → Mkt Perform
2015-08-13	Reiterato	Stifel	Buy
2015-07-23	Reiterato	Canaccord Genuity	Buy

Mostra tutto

Idexx Laboratories Inc Borsa (IDXX) Ultime notizie

Jan 08, 2026

Is IDEXX Laboratories Inc. (IX1) stock at risk of policy regulationMarket Performance Summary & Real-Time Chart Pattern Alerts - ulpravda.ru

Jan 08, 2026

How IDEXX Laboratories Inc. stock trades before earningsAnalyst Downgrade & Real-Time Sentiment Analysis - ulpravda.ru

Jan 08, 2026

Is IDEXX Laboratories Inc. (IX1) stock undervalued historicallyJuly 2025 Rallies & Expert Approved Trade Ideas - ulpravda.ru

Jan 08, 2026

Will IDEXX Laboratories Inc. stock deliver consistent dividends2025 Market Trends & Weekly High Conviction Ideas - ulpravda.ru

Jan 08, 2026

Is IDEXX Laboratories Inc. stock attractive after correction2025 Earnings Surprises & AI Powered Market Entry Strategies - ulpravda.ru

Jan 08, 2026

Can IDEXX Laboratories Inc. (IX1) stock deliver double digit returnsQuarterly Risk Review & Capital Efficient Trading Techniques - ulpravda.ru

Jan 08, 2026

Veterinary Infectious Disease Diagnostics Market Forecast, 2025-2035, Featuring IDEXX Labs, Zoetis, Thermo Fisher Scientific, Virbac, bioMerieux and More - Yahoo Finance

Jan 08, 2026

Palo Alto, Capital One Financial, IDEXX Laboratories And Others: CNBC's 'Closing Trades' - Bitget

Jan 08, 2026

Palo Alto, Capital One Financial, IDEXX Laboratories And More: CNBC's 'Final Trades' - Benzinga

Jan 08, 2026

Jan 07, 2026

Is the current sentiment towards IDEXX Laboratories Inc positive or negative in the market? - Bitget

Jan 07, 2026

What catalysts could drive IDEXX Laboratories Inc. stock higher2026 world cup usa national team third place match young talents set piece tactics winner prediction tactical review - ulpravda.ru

Jan 06, 2026

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

Jan 06, 2026

What to expect from IDEXX Laboratories’ next quarterly earnings report - MSN

Jan 06, 2026

2026 world cup key players explained: Can IDEXX Laboratories Inc. stock deliver surprise earnings beat2026 world cup usa national team round of 16 playmakers high defensive line odds analysis preview - ulpravda.ru

Jan 06, 2026

Jan 05, 2026

IDEXX Laboratories' SWOT analysis: stock outlook amid vet visit trends - MSN

Jan 05, 2026

What to Expect From IDEXX Laboratories’ Next Quarterly Earnings Report? - inkl

Jan 05, 2026

Railway Pension Investments Ltd Has $189.45 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Jan 05, 2026

Jan 04, 2026